IN8bio, Inc. (INAB) Balance Sheet

NASDAQ: INABAssets, liabilities, debt and equity over 8 years.

INAB balance sheet, 2025

December 31, 2025 · U.S. dollars

$32.3M assets = $4.7M liabilities + $27.6M equity

What it owns$32.3MCash & ST investments: $27.1M (83.9%)Cash & ST investments$27.1M · 84%Other current: $788,000 (2.4%)PP&E: $4.0M (12.5%)PP&E$4.0M · 13%Other non-current: $366,000 (1.1%)=How it is financed$32.3MCurrent liabilities: $3.2M (9.8%)Current liabilities $3.2MOther LT liabilities: $1.6M (4.8%)Shareholders’ equity: $27.6M (85.4%)Shareholders’ equity$27.6M · 85%

Both columns are drawn to the same scale: what INAB owns equals what it owes plus shareholders’ equity. Hover a block for its value.

INAB financial health

Current ratio8.82
Comfortable · current assets cover current liabilities 8.82×
Debt / equity0.10
Low leverage · $0.10 of debt for each $1 of equity
Equity / assets85.4%
Equity-funded · of assets funded by shareholders
Cash / debt973.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

INAB balance sheet trends, 2018–2025

IN8bio, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$5.9M2018$32.3M2025+27.5%/yr
Total liabilities$1.2M2018$4.7M2025+20.9%/yr
Shareholders’ equity$4.6M2018$27.6M2025+29.0%/yr
Cash & short-term investments$5.0M2018$27.1M2025+27.3%/yr
Total debt$174,0002020$2.8M2025+74.1%/yr
Net cash (debt)$17.8M2020$24.3M2025+$6.5M
Working capital$4.7M2018$24.7M2025+$20.1M
Current ratio12.1120188.822025−3.29
Debt / equity0.0120200.102025+0.09

Change is the average annual growth (CAGR) or the difference between the first and latest year.

INAB assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

INAB liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

INAB debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

INAB balance sheet

IN8bio, Inc. annual balance sheet
20252024202320222021202020192018
Assets
Cash & short-term investments$27.1M$11.1M$21.3M$18.2M$37.0M$18.0M$610,000$5.0M
Cash & equivalents$27.1M$11.1M$21.3M$18.2M$37.0M$18.0M$610,000$5.0M
Receivables$0$0$0$0$0$0$0$30,000
Inventory$0$0$0$0$0$0$0$15,000
Other current assets$788,000$1.5M$3.3M$4.1M$2.0M$150,000$153,000$37,000
Total current assets$27.9M$12.6M$24.6M$22.2M$39.0M$18.1M$763,000$5.1M
Property, plant & equipment (net)$4.0M$7.8M$8.6M$10.3M$2.8M$186,000$274,000$795,000
Goodwill & intangible assets$0$0$0$126,000$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0
Other non-current assets$366,000$541,000$511,000$381,000$409,000$2.6M$93,000$28,000
Total assets$32.3M$20.9M$33.7M$33.0M$42.2M$20.9M$1.1M$5.9M
Liabilities
Accounts payable$309,000$389,000$924,000$2.1M$395,000$620,000$560,000$419,000
Short-term debt$1.2M$1.6M$1.5M$1.4M$626,000$174,000——
Total current liabilities$3.2M$3.1M$5.4M$5.8M$2.3M$2.6M$647,000$419,000
Long-term debt$0$0$0$0$0$0$0$0
Lease obligations$2.8M$5.0M$4.9M$5.9M$2.4M$0——
Other long-term liabilities$1.6M$3.4M$3.4M$4.5M$1.8M$17,000$829,000$829,000
Total liabilities$4.7M$6.5M$8.8M$10.3M$4.0M$2.6M$1.5M$1.2M
Shareholders' equity
Common stock & paid-in capital$10,000$7,000$4,000$3,000$2,000$1,000$1,000$1,000
Retained earnings (deficit)−$141.1M−$121.7M−$91.2M−$61.2M−$32.7M−$18.0M−$9.5M−$4.3M
Accumulated other comprehensive income————−$42.2M−$257,000−$169,000−$133,000
Total shareholders' equity$27.6M$14.5M$24.9M$22.7M$38.2M$18.3M−$346,000$4.6M
Key figures
Total debt$2.8M$5.0M$4.9M$5.9M$2.4M$174,000——
Net cash (debt)$24.3M$6.1M$16.4M$12.3M$34.6M$17.8M——
Working capital$24.7M$9.5M$19.2M$16.4M$36.7M$15.6M$116,000$4.7M
Tangible book value$27.6M$14.5M$24.9M$22.6M$38.2M$18.3M−$346,000$4.6M
Book value per share$6.30———————
Shares outstanding4.4M———————
Current ratio8.824.084.573.8217.287.051.1812.11
Quick ratio8.573.613.953.1216.417.000.9411.98
Debt / equity0.100.350.200.260.060.01——
Equity / assets85.4%69.1%74.0%68.8%90.4%87.6%−30.6%78.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 12, 2026); data from EODHD.

INAB financial position

At the end of fiscal 2025 (December 31, 2025), IN8bio had total assets of $32.3 million (up 54.1% from a year earlier), total liabilities of $4.7 million and shareholders' equity of $27.6 million. It held $27.1 million in cash and short-term investments against $2.8 million of debt, a net cash position of $24.3 million. Its current ratio was 8.82. In the latest quarter (ended June 30, 2026) total assets were $21.7 million and equity $18.4 million.

Related: INAB income statement, INAB cash flow statement, INAB key metrics. See the INAB stock overview for the latest quote and news.

INAB balance sheet FAQ

What are IN8bio's total assets?

IN8bio reported total assets of $32.3 million at the end of fiscal 2025 (December 31, 2025), compared with $20.9 million a year earlier.

How much debt does IN8bio have?

IN8bio had $2.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.10.

How much cash does IN8bio have?

IN8bio held $27.1 million in cash and short-term investments at the end of fiscal 2025; with $2.8 million of debt that is net cash of $24.3 million.

What is IN8bio's book value?

IN8bio's shareholders' equity (book value) was $27.6 million at the end of fiscal 2025, or $6.30 per share.

What is IN8bio's current ratio?

IN8bio had current assets of $27.9 million and current liabilities of $3.2 million, a current ratio of 8.82 (it can cover its short-term obligations).

Biotechnology: balance sheet